⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Keenfolks Launches KEENFOLKS X_
businesswire.com
KO
DEO
MRK
Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation
prnewswire.com
MRK
FDA Approves BRAVECTO ® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs
businesswire.com
MRK
Evinature's CurQD Chosen for DoD-Funded Clinical Trial to Investigate Combination Approach for Ulcerative Colitis
prnewswire.com
MRK
Kelun-Biotech to Present the Final OS Analysis of Sacituzumab Tirumotecan (Sac-TMT) from the OptiTROP-Lung03 Study
prnewswire.com
MRK
Phanes Therapeutics to Present Three Clinical Posters at AACR 2026
prnewswire.com
MRK
MilliporeSigma Marks 10 Years of SPARK (TM) Mobilizing Employee Volunteers to Help Inspire the Next Generation in STEM
accessnewswire.com
MRK
MilliporeSigma Marks 10 Years of SPARK™ Mobilizing Employee Volunteers to Help Inspire the Next Generation in STEM
globenewswire.com
MRK
Merck Marks 10 Years of SPARK™ Mobilizing Employee Volunteers to Help Inspire the Next Generation in STEM
globenewswire.com
MRK
Synthekine Announces AACR 2026 Oral Presentation of Updated Phase 1a/1b Clinical and Translational Data for STK‑012 in First‑Line Nonsquamous NSCLC with Features of Immunotherapy Resistance
businesswire.com
MRNA
MRK